313 related articles for article (PubMed ID: 15114594)
1. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience.
Tomizawa D; Imai K; Ito S; Kajiwara M; Minegishi Y; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Am J Hematol; 2004 May; 76(1):33-9. PubMed ID: 15114594
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team.
Tsuji Y; Imai K; Kajiwara M; Aoki Y; Isoda T; Tomizawa D; Imai M; Ito S; Maeda H; Minegishi Y; Ohkawa H; Yata J; Sasaki N; Kogawa K; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Bone Marrow Transplant; 2006 Mar; 37(5):469-77. PubMed ID: 16435016
[TBL] [Abstract][Full Text] [Related]
3. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
5. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry.
Gross TG; Filipovich AH; Conley ME; Pracher E; Schmiegelow K; Verdirame JD; Vowels M; Williams LL; Seemayer TA
Bone Marrow Transplant; 1996 May; 17(5):741-4. PubMed ID: 8733691
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
[TBL] [Abstract][Full Text] [Related]
8. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome.
Dimicoli S; Bensoussan D; Latger-Cannard V; Straczek J; Antunes L; Mainard L; Dao A; Barbe F; Araujo C; Clément L; Feugier P; Lecompte T; Stoltz JF; Bordigoni P
Bone Marrow Transplant; 2003 Oct; 32(7):733-7. PubMed ID: 13130323
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
[TBL] [Abstract][Full Text] [Related]
11. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
12. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
13. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
[TBL] [Abstract][Full Text] [Related]
14. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience.
Al-Dhekri H; Al-Mousa H; Ayas M; Al-Muhsen S; Al-Ghonaium A; Al-Ghanam G; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Ahmari A; Al-Jefri A; Al-Mahr M; El-Solh H
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1245-9. PubMed ID: 21220036
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
18. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
19. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
[TBL] [Abstract][Full Text] [Related]
20. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
